Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chesney

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
American Heart Journal|September 30, 2000
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)C M Chesney, M B Elam, J A Herd, et al.
The New England Journal of Medicine|April 4, 1974
Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patientsJ A Ryan, R M Abel, W M Abbott, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 30, 2026
From birth to beyond: predicting incidence and timing of CSF diversion in postnatal MMC closureKatherine Daniels, Kelsi M Chesney, Brannan E O'Neill, et al.
Psychosomatic Medicine|September 1, 1995
Psychobiologic reactivity to stress and childhood respiratory illnesses: results of two prospective studiesW T Boyce, M Chesney, A Alkon, et al.
AIDS Care|November 7, 2002
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infectionG N Colfax, J S Lehman, A B Bindman, et al.
The Journal of Infectious Diseases|May 1, 1995
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trialJ O Kahn, K S Steimer, J Baenziger, et al.
AIDS Care|February 23, 2008
A randomized comparison of two instruments for measuring self-reported antiretroviral adherenceS Mannheimer, L Thackeray, K Huppler Hullsiek, et al.
The Journal of Infectious Diseases|February 22, 2001
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP StudyJ O Kahn, J N Martin, M E Roland, et al.
Cells|March 14, 2026
Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor SurveillanceKelsi M Chesney, Jeffrey R Whiteaker, Brian Hood, et al.
The Journal of Infectious Diseases|May 6, 1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcomeS G Deeks, N S Hellmann, R M Grant, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
American Heart Journal|September 30, 2000
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)C M Chesney, M B Elam, J A Herd, et al.
The New England Journal of Medicine|April 4, 1974
Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patientsJ A Ryan, R M Abel, W M Abbott, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 30, 2026
From birth to beyond: predicting incidence and timing of CSF diversion in postnatal MMC closureKatherine Daniels, Kelsi M Chesney, Brannan E O'Neill, et al.
Psychosomatic Medicine|September 1, 1995
Psychobiologic reactivity to stress and childhood respiratory illnesses: results of two prospective studiesW T Boyce, M Chesney, A Alkon, et al.
AIDS Care|November 7, 2002
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infectionG N Colfax, J S Lehman, A B Bindman, et al.
The Journal of Infectious Diseases|May 1, 1995
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trialJ O Kahn, K S Steimer, J Baenziger, et al.
AIDS Care|February 23, 2008
A randomized comparison of two instruments for measuring self-reported antiretroviral adherenceS Mannheimer, L Thackeray, K Huppler Hullsiek, et al.
The Journal of Infectious Diseases|February 22, 2001
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP StudyJ O Kahn, J N Martin, M E Roland, et al.
Cells|March 14, 2026
Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor SurveillanceKelsi M Chesney, Jeffrey R Whiteaker, Brian Hood, et al.
The Journal of Infectious Diseases|May 6, 1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcomeS G Deeks, N S Hellmann, R M Grant, et al.
Pageof 14